Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial

著者: Hong Sun, David W. Dodick, Stephen D. Silberstein, Peter J. Goadsby, Uwe Reuter, Messoud Ashina, Joel R. Saper, Roger Cady, Yun Chon, Julie Dietrich, Robert Lenz - The Lancet 2016 被引用: 360